Cases 21 - 30 of 58
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD. et al
as 2:2021cv10403
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED and SALIX PHARMACEUTICALS, INC.
Defendant:
AGILA SPECIALTIES INC., MYLAN INC., MYLAN PHARMACEUTICALS INC. A VIATRIS COMPANY and others
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv01395
Plaintiff:
Pfizer Inc., Warner-Lambert Company LLC and PF PRISM IMB B.V.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00445
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MERCK SHARP & DOHME B.V. et al v. MYLAN API US LLC et al
as 2:2020cv03270
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN API US LLC
Plaintiff:
ORGANON USA INC. and MERCK SHARP & DOHME B.V.
Cause Of Action: 35 U.S.C. § 271
CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. et al
as 3:2020cv03168
Plaintiff:
CUBIST PHARMACEUTICALS LLC
Defendant:
MYLAN INC., MYLAN PHARMACEUTICALS INC. and MYLAN N.V.
Cause Of Action: 35 U.S.C. § 271
CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. et al
as 2:2020cv03168
Plaintiff:
CUBIST PHARMACEUTICALS LLC
Defendant:
MYLAN INC., MYLAN PHARMACEUTICALS INC. and MYLAN N.V.
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2020cv02749
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH US, LLC and others
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2020cv02608
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2019cv22231
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
